Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials-Reference-Cited by-同舟云学术

Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials

Published:2003-03-06 Issue:6 Volume:36 Page:417-425
ISSN:0001-4842
Container-title:Accounts of Chemical Research
language:en
Short-container-title:Acc. Chem. Res.

Author:

Meijer Laurent¹,Raymond Eric¹

Affiliation:

1. Station Biologique de Roscoff, C.N.R.S., BP 74, 29682 Roscoff Cedex, Bretagne, France, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10021-6399, and Department of Medicine, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94815 Villejuif Cedex, France

Publisher

American Chemical Society (ACS)

Subject

General Medicine,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ar0201198

Reference61 articles.

1. Protein kinases — the major drug targets of the twenty-first century?

2. Stimulation of protein phosphorylation during fertilization-induced maturation of Urechis caupo oocytes

Cited by 327 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases;Biochemical Pharmacology;2024-11

2. Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation – A systematic computational approach to discover novel cancer therapeutics;Computational Biology and Chemistry;2024-10

3. Self‐Assembled PD‐L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition;Small;2024-06-10

4. Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early intervention after TBI;Experimental & Molecular Medicine;2024-01-10

5. Coumarin–amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition;RSC Advances;2024